<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2019-21-274-278</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-5505</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДИССЕРТАНТ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DISSERTANT</subject></subj-group></article-categories><title-group><article-title>Антенатальная гибель плода у беременных женщин с холестатическим поражением печени</article-title><trans-title-group xml:lang="en"><trans-title>Fetal death in the women with cholestasis pregnancy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3628-5146</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Качковский</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kachkovskiy</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>443001, Россия, Самара, ул. Чапаевская, д. 227</p></bio><bio xml:lang="en"><p>Mikhail A. Kachkovskiy, Professor, Professor of the Department of Internal Medicine</p><p>227, Chapaevskaya St., Samara, 443001, Russia</p></bio><email xlink:type="simple">KachkovskyMA@reaviz.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9619-1435</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кошелева</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kosheleva</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>443001, Россия, Самара, ул. Чапаевская, д. 227</p></bio><bio xml:lang="en"><p>Olga V. Kosheleva, postgraduate</p><p>227, Chapaevskaya St., Samara, 443001, Russia</p></bio><email xlink:type="simple">Koshel-olga@ya.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Медицинский университет «Реавиз»<country>Россия</country></aff><aff xml:lang="en">Medical University «Reaviz»<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>28</day><month>01</month><year>2020</year></pub-date><volume>0</volume><issue>21</issue><fpage>274</fpage><lpage>278</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Качковский М.А., Кошелева О.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Качковский М.А., Кошелева О.В.</copyright-holder><copyright-holder xml:lang="en">Kachkovskiy M.A., Kosheleva O.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/5505">https://www.med-sovet.pro/jour/article/view/5505</self-uri><abstract><p>При холестатическом поражении печени (ХПП) у беременных возможно развитие антенатальной гибели плода.</p><sec><title>Цель исследования</title><p>Цель исследования. Определить взаимосвязь клинико-анамнестических и лабораторных показателей беременных женщин с ХПП с антенатальной гибелью плода.</p></sec><sec><title>Пациенты и методы</title><p>Пациенты и методы. Обследованы 211 беременных женщин. Основная группа – 144 (68%) женщины с ХПП, контрольная – 67 (32%) пациенток без признаков данного заболевания. Выделено две подгруппы в зависимости от наличия или отсутствия антенатальной гибели плода у беременных с ХПП. Выполнен комплекс стандартных клинико-диагностических исследований, включая акушерское УЗИ и кардиотокографию. Результаты. В группе пациенток с ХПП досто- верно чаще встречались послеродовые кровотечения (р&lt;0,05), внутриутробная гипоксия плода (р&lt;0,001), антенатальная гибель отмечалась только в основной группе (2,1%). В обеих подгруппах чаще имели место выкидыши в анамнезе (p = 0,019). У большинства женщин с ХПП имели место заболевания гепатобилиарной системы, гестационная артериальная гипертензия и болезни почек (р&lt;0,05). В подгруппе с антенатальной гибелью достоверно чаще встречалась артериальная гипертензия, существовавшая до беременности (р&lt;0,05). У пациенток с ХПП и антенатальной гибелью кожный зуд имел исключительно постоянный характер. Подгруппа с антенатальной гибелью существенно отличалась от контрольной группы по гиперферментемии как в период беременности (аланинаминотрансфераза (АЛТ) – p&lt;0,001, аспартатаминотрансфераза (АСТ) – p = 0,001, щелочная фосфатаза (ЩФ) – p = 0,001), так и после родоразрешения (АЛТ – p = 0,002, АСТ – p = 0,033, ЩФ – p = 0,006).</p></sec><sec><title>Заключение</title><p>Заключение. Женщины с ХПП, выкидышем в анамнезе или артериальной гипертензией, существовавшей ранее, относятся к группе риска антенатальной гибели плода. Необходимо более частое исследование состояние плода у пациенток с постоян- ным кожным зудом при ХПП.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. The development of fetal death among pregnant women with cholestasis pregnancy (CP) is possible.</p></sec><sec><title>Aim</title><p>Aim. The purposeи is to determine the interconnection between clinico-anamnestic and laboratory indicators of pregnant women with CP and fetal death.</p></sec><sec><title>Patients and methods</title><p>Patients and methods. 211 pregnant women were examined. The main group – 144 (68%) women with CP, control</p><p>group – 67 (32%) patients without symptoms of this disease. There are 2 subgroups depending on the presence or absence of fetal death among pregnant women with CP. A complex of standard clinical and diagnostic studies was performed, including obstetric ultrasound and cardiotocography. Results. In the group of patients with CP, postpartum hemorrhages (p&lt;0.05), intrauterine fetal hypoxia (p&lt;0.001) were significantly more frequent, fetal death was noted only in the main group (2.1%). In both subgroups miscarriages were more common in the history (p = 0.019). Most women with CHP had diseases of the hepatobiliary system, gestational hypertension and kidney disease (p&lt;0.05). In the subgroup with fetal death arterial hypertension existed significantly more frequent before pregnancy (p&lt;0.05). The itchy skin was extremely permanent among patients with CP and fetal death. The subgroup with fetal death significantly differed from the control group for hyperfermentemia both during pregnancy (alanine transaminase (ALT) – p&lt;0.001, aspartate transaminase (AST) – p = 0.001, alkaline phosphatase (APH) – p = 0.001), and after delivery (ALT –p = 0.002, AST – p = 0.033, APH – p = 0.006).</p></sec><sec><title>Conclusions</title><p>Conclusions. Women with CP, with a miscarriage in anamnesis or hypertension are in a risk group of fetal death. A more frequent study of the fetal condition is needed among patients with persistent itching at CP.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>холестатическое поражение печени у беременных</kwd><kwd>внутрипеченочный холестаз</kwd><kwd>гепатоз беременных</kwd><kwd>антенатальная гибель</kwd><kwd>осложнения гестации</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cholestatic liver disease in pregnant women</kwd><kwd>intrahepatic cholestasis</kwd><kwd>hepatosis of pregnancy</kwd><kwd>intrauterine fetal death</kwd><kwd>complications of pregnancy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Апресян С.В. Беременность и роды при экстрагенитальных заболеваниях. 2-е изд. М.: ГЭОТАР-Медиа; 2015; 536 с.</mixed-citation><mixed-citation xml:lang="en">Apresyan S.V. Pregnancy and childbirth with extragenital diseases. Ed. 2nd. Moscow, GEOTAR-Media Publ., 2015: 536 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Успенская Ю.Б., Кузнецова И.В., Шептулин А.А., Гончаренко Н.В., Герасимов А.Н., Амирсаламова М.М. Прием препаратов половых гормонов как фактор риска развития внутрипеченочного холестаза беременных и билиарного сладжа у беременных. Рос журн гастроэнтерол гепатол колопроктол 2018; 28(4):55-65. doi: 10.22416/1382-4376-2018-28-4-55-65.</mixed-citation><mixed-citation xml:lang="en">Uspenskaya Y.B., Kuznetsova I.V., Sheptulin A.A., Goncharenko N.V., Gerasimov A.N., Amirsalamova M.M. Administration of Sex Hormone Preparations as a Risk Factor in the Development of Intrahepatic Cholestasis of Pregnancy and Biliary Sludge in Pregnant Women. Rus J Gastroenterol Hepatol Coloproctol. 2018; 28(4):55–65. doi: 10.22416/1382-4376-2018-28-4-55-65.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Клименченко Н.И., Ходжаева З.С., Шмаков Р.Г., Федорова Т.А., Иванец Т.Ю., Баев О.Р. и др. Диагностика и лечение внутрипечено ного холестаза беременных. Клинические рекомендации. Акушерство и гинекология. 2017;(1):112–119. doi: 10.18565/aig.2017.1.112-119.</mixed-citation><mixed-citation xml:lang="en">Klimenchenko N.I., Khodzhaeva Z.S., Shmakov R.G., Fedorova T.A., Ivanets T.Yu., Baev O.R., et al. Diagnosis and treatment of intrahepatic cholestasis of pregnancy. Clinical recommendations. Akusherstvo i ginekologiya = Obstetrics and Gynegology. 2017;(1):112–119. (In Russ.) doi: 10.18565/aig.2017.1.112-119.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Линева О.И., Романова Е.Ю. Холестатический гепатоз беременных: патогенетические подходы к выбору методов лечения. Практическая медицина. 2009;2:77–81. Режим доступа: https://elibrary.ru/item.asp?id = 17772315.</mixed-citation><mixed-citation xml:lang="en">Lineva O.I., Romanova E.Y. Cholestatic hepatosis of pregnant women: pathogenetic approaches to a choice of methods of treatment. Prakticheskaya meditsina = Practical medicine. 2009;2:77–81. (In Russ.) Available at: https://elibrary.ru/item.asp?id =17772315.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Turunen K., Sumanen M., Haukilahti R.L., Kirkinen P., Mattila K. Good pregnancy outcome despite intrahepatic сholestasis. Scand. J. Prim. Health Care. 2010;28:102–107. doi: 10.3109/02813431003784001.</mixed-citation><mixed-citation xml:lang="en">Turunen K., Sumanen M., Haukilahti R.L., Kirkinen P., Mattila K. Good pregnancy outcome despite intrahepatic сholestasis. Scand. J. Prim. Health Care. 2010;28:102–107. doi: 10.3109/02813431003784001.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Estiu M.C., Frailuna М.А., Otero С., Dericco М., Williamson С., Marin J.G., Macias R. Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid. PLoS One. 2017;12(4):e0176504. doi: 10.1371/journal.pone.0176504.</mixed-citation><mixed-citation xml:lang="en">Estiu M.C., Frailuna М.А., Otero С., Dericco М., Williamson С., Marin J.G., Macias R. Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid. PLoS One. 2017;12(4):e0176504. doi: 10.1371/journal.pone.0176504.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Herrera C.A., Manuck T.A., Stoddard G.J., Varner M.W., Esplin S., Clark E.A.S., et al. Perinatal outcomes associated with intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med. 2018;31(14):1913–1920. doi: 10.1080/14767058.2017.1332036.</mixed-citation><mixed-citation xml:lang="en">Herrera C.A., Manuck T.A., Stoddard G.J., Varner M.W., Esplin S., Clark E.A.S., et al. Perinatal outcomes associated with intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med. 2018;31(14):1913–1920. doi: 10.1080/14767058.2017.1332036.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ibrahim E., Diakonov I., Arunthavarajah D., Swift T., Goodwin M., McIlvride S., Nikolova V., Williamson C., Gorelik J. Bile acids and their respective conjugates elicit different responses in neonatal cardiomyocytes: role of Gi protein, muscarinic receptors and TGR5. Sci Rep. 2018;8(1):Р 7110. doi: 10.1038/s41598-018-25569-4.</mixed-citation><mixed-citation xml:lang="en">Ibrahim E., Diakonov I., Arunthavarajah D., Swift T., Goodwin M., McIlvride S., Nikolova V., Williamson C., Gorelik J. Bile acids and their respective conjugates elicit different responses in neonatal cardiomyocytes: role of Gi protein, muscarinic receptors and TGR5. Sci Rep. 2018;8(1):Р 7110. doi: 10.1038/s41598-018-25569-4.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ковалева Н.Б., Байрамова И.Х. Внутрипеченочный холестаз беременных. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2006;16(3):36–39. Режим доступа: http://www.m-vesti.ru/arch/arch.html.</mixed-citation><mixed-citation xml:lang="en">Kovaleva N.B., Bayramova I.Kh. Intrahepatic cholestasis of pregnancy. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2006;16(3):36–39. Available at: http://www.m-vesti.ru/arch/arch.html.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Furrer R., Winter K., Schäffer L., Zimmermann R., Burkhardt T., Haslinger C. Postpartum Blood Loss in Women Treated for Intrahepatic Cholestasis of Pregnancy. Obstet Gynecol. 2016;128(5):1048–1052. doi: 10.1097/AOG.0000000000001693.</mixed-citation><mixed-citation xml:lang="en">Furrer R., Winter K., Schäffer L., Zimmermann R., Burkhardt T., Haslinger C. Postpartum Blood Loss in Women Treated for Intrahepatic Cholestasis of Pregnancy. Obstet Gynecol. 2016;128(5):1048–1052. doi: 10.1097/AOG.0000000000001693.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lisman T., Bernal W. Hemostatic issues in pregnancy-induced liver disease. Thromb. Res. 2017;151(1):S78–S81. doi: 10.1016/S0049-3848(17)30073-7.</mixed-citation><mixed-citation xml:lang="en">Lisman T., Bernal W. Hemostatic issues in pregnancy- induced liver disease. Thromb. Res. 2017;151(1):S78–S81. doi: 10.1016/S0049-3848(17)30073-7.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
